Home/Filings/4/0000899243-23-000989
4//SEC Filing

Santillana Sergio L. 4

Accession 0000899243-23-000989

CIK 0001835579other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:15 PM ET

Size

5.4 KB

Accession

0000899243-23-000989

Insider Transaction Report

Form 4
Period: 2023-01-03
Santillana Sergio L.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-03+105,000105,000 total
    Exercise: $2.62Exp: 2033-01-03Common Stock (105,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Issuer

Ikena Oncology, Inc.

CIK 0001835579

Entity typeother

Related Parties

1
  • filerCIK 0001708767

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:15 PM ET
Size
5.4 KB